Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of two regimens for unfavorable vaginal bleeding in women using the etonogestrel implant
PACTR202508557960619Not yet recruiting
- Sponsor
- Ajayi Tejumade
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of mifepristone and doxycycline in menstrual disorders and Irregular Menstruation (2 arms), sponsored by Ajayi Tejumade. Primary endpoint: Mean number of days to cessation of bleeding. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
mifepristonedoxycycline
03
Conditions
menstrual disordersIrregular Menstruation
Beyond the preview
Go deeper on PACTR202508557960619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202508557960619.